Please login to the form below

Innovative Trials wins the Queen’s Award

Innovative Trials presented with Queen’s Award for international excellence in clinical trial patient recruitment

Innovative Trials, a company specialising in clinical trial patient recruitment and community engagement, has been honoured with a Queen’s Award for Enterprise for its outstanding work, both in the UK and internationally, to help pharmaceutical companies and Clinical Research Organisations (CROs) bring new medicines to market.

The award, which was presented to Kate Shaw and David Watkins, co-founders of Innovative Trials, at the company’s headquarters on Friday 26 June, is a mark of business excellence with winners personally approved by Her Majesty The Queen.

Kate Shaw, Innovative Trials’ co-founder and CEO, said: “We’re delighted and humbled to receive a Queen’s Award for Enterprise in the field of International Trade. Everything we do is driven by the desire to get life-changing treatments to patients faster, so we work extremely hard to support our clients’ needs across the globe. We know how vital new medicines are to patients, especially as our understanding of conditions increase and treatments get more targeted, and how costly recruitment delays can be for those funding the trials, so we do everything in our power to ensure clinical research studies have the participants they need to reach a successful endpoint.

“In the ten years that Innovative Trials has been running so far, we have helped recruit and retain around 40,000 people into clinical trials. It’s something we are incredibly proud of and why it is fantastic to now receive a royal seal of approval for our work.”

Founded in 2010, Innovative Trials works with some of the biggest pharmaceutical companies and CROs globally to help them reach their patient recruitment targets for trials, keep patients engaged throughout the research process and avoid costly delays in bringing effective new treatments to market. To date, the company has worked on nearly 200 clinical trials and played a part in six new treatments being approved for patients across the world. In 2020, the company launched a campaign alongside COUCH Health and Egality to ensure patients from under-represented ethnic groups are fairly represented in clinical research.

The Queen’s Awards for Enterprise recognise and celebrate business excellence in the UK. They are the most prestigious business awards in the country, with winners selected for their outstanding success. It is an endorsement of the highest standard and, for Innovative Trials, will remain in place until 2025.

About The Queen’s Award

The Queen’s Awards for Enterprise recognise and encourage the outstanding achievements of UK businesses in the fields of:
● Innovation;
● International Trade;
● Sustainable Development; and,
● Promoting Opportunity (through social mobility).
Now in its 55th year, the Queen’s Awards for Enterprise recognise and celebrate business excellence in the UK. They are the most prestigious business awards in the country, with winners selected for their outstanding success.
For more information about the Queen’s Awards for Enterprise, visit

About Innovative Trials

Founded in 2010, Innovative Trials works alongside pharmaceutical and clinical research organisations to ensure that patients enrol onto clinical trials in a timely manner and are fully informed of what the research will involve for themselves and their families. This enables potential new treatments to come to market as early as possible to provide alternative therapeutic options for present and future patients.
Based in Letchworth Garden City in Hertfordshire, Innovative Trials employs around 64 members of staff in the UK. The company works internationally with a further 70 people stationed overseas in 70 countries to help clinical trial researchers recruit eligible patients and keep them involved.
For more information, visit

20th September 2021



Company Details

Innovative Trials

+44 (0) 1707 378 581

Contact Website

Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
United Kingdom

Latest content on this profile

Kate Shaw comments the appointment of an independent review on clinical trials in the UK.
The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five years.
Innovative Trials
Patient Recruitment: Think Global, Act Local
Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust data - but also promotes health equity and research and innovation across continents.Another benefit of global clinical trials is the potential for these studies to be completed more quickly and efficiently [1]. However, around four in five clinical trials fail to meet their patient recruitment deadlines [2], which delays patient access to innovative new therapeutics and can prove costly to Sponsors.Just as treatments are becoming more personalized, so should clinical trial patient recruitment strategies. A ‘one size fits all’ approach to enrollment fails to consider how factors such as an individual country’s culture, healthcare structure and patients’ needs can affect a site’s ability to recruit eligible participants. The key to patient enrollment success is to ‘think local’, even for global studies.In this webinar, we will:Discuss the benefits of using a diversified patient recruitment approach for each country within a global studyInvestigate how patient recruitment strategies can differ from country to country,Hear from two in-country patient recruitment specialists about the challenges relevant to their regions and how they work with sites to overcome theseShare how Innovative Trials’ ‘boots-on-the-ground’ approach in more than 70 countries around the world can help accelerate patient recruitment and retention for your clinical trials.SpeakersGeorgia Hardy - Site Operations Lead, Innovative TrialsNicole Yingst - Associate Director, Patient Recruitment Programs, PfizerBarbara OrlosKaminska - Clinical Enrollment Manager (Poland), Innovative Trials
Innovative Trials
Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
Innovative Trials
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Innovative Trials
Innovative Trials on the latest ABPI report
Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Innovative Trials
Innovative Trials featuring in a Clinical Trials Arena article
Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Innovative Trials